SELLAS Life Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLS and other ETFs, options, and stocks.

About SLS

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. 

CEO
Angelos M. Stergiou
CEOAngelos M. Stergiou
Employees
13
Employees13
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2006
Founded2006
Employees
13
Employees13

SLS Key Statistics

Market cap
2.11B
Market cap2.11B
Price-Earnings ratio
-49.56
Price-Earnings ratio-49.56
Dividend yield
Dividend yield
Average volume
6.84M
Average volume6.84M
High today
$12.59
High today$12.59
Low today
$11.22
Low today$11.22
Open price
$12.33
Open price$12.33
Volume
6.73M
Volume6.73M
52 Week high
$15.88
52 Week high$15.88
52 Week low
$1.39
52 Week low$1.39

Stock Snapshot

SELLAS Life Sciences(SLS) stock is priced at $11.31, giving the company a market capitalization of 2.11B. It carries a P/E multiple of -49.56.

On 2026-07-25, SELLAS Life Sciences(SLS) stock moved within a range of $11.22 to $12.59. With shares now at $11.31, the stock is trading +0.8% above its intraday low and -10.2% below the session's peak.

Trading volume for SELLAS Life Sciences(SLS) stock has reached 6.73M, versus its average volume of 6.84M.

Over the past 52 weeks, SELLAS Life Sciences(SLS) stock has traded between a high of $15.88 and a low of $1.39.

Over the past 52 weeks, SELLAS Life Sciences(SLS) stock has traded between a high of $15.88 and a low of $1.39.

SLS News

Simply Wall St 2d
Is SELLAS Life Sciences Group Fully Priced As Regal Trial Debate Heats Up?

SELLAS Life Sciences Group (SLS) stock is back in focus after CEO Angelos Stergiou said the Regal Phase 3 trial is nearing its 80 event trigger, while Martin Sh...

Is SELLAS Life Sciences Group Fully Priced As Regal Trial Debate Heats Up?
Simply Wall St 7d
SELLAS Life Sciences Group Stock Trades At A Premium On Book Value Despite A 7x Return

SELLAS Life Sciences Group stock has delivered a very large three year return while the broader valuation checks suggest the shares are expensive rather than a...

SELLAS Life Sciences Group Stock Trades At A Premium On Book Value Despite A 7x Return

People also own

Based on the portfolios of people who own SLS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.